BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6745761)

  • 21. Letter: Serum-copper in Hodgkin's disease before and after herpes zoster.
    Thorling EB; Thorling K
    Lancet; 1974 Dec; 2(7893):1396-7. PubMed ID: 4143363
    [No Abstract]   [Full Text] [Related]  

  • 22. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
    Jamakovic M; Baljic R
    Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of serum copper levels in adult patients with Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
    Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
    [No Abstract]   [Full Text] [Related]  

  • 24. [Zinc and copper blood levels in patients with Hodgkin's disease].
    Adamczyk B; Glińska H; Kulpa J; Pawlicki M
    Nowotwory; 1974; 24(1):9-15. PubMed ID: 4824380
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum copper in Hodgkin's disease in children.
    Tessmer CF; Hrgovcic M; Wilbur J
    Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrotic syndrome in Hodgkin's disease].
    Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
    Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
    Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
    Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum copper content and ceruloplasmin activity in children with lymphogranulomatosis].
    Dmitrieva LV
    Vopr Okhr Materin Det; 1967 Feb; 12(2):37-40. PubMed ID: 5611374
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of various cytostatics and radiotherapy on serum iron and copper levels in lymphoma patients].
    Georgieva B; Gekova K; Arsov Ts
    Vutr Boles; 1982; 21(6):91-6. PubMed ID: 6897690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hodgkin's disease. Lymphoadenography, cupremia and sideremia].
    Weissleder H; Marongiu F
    Prensa Med Argent; 1966 May; 53(18):1001-7. PubMed ID: 5916206
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
    Thorling EB; Thorling K
    Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
    Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
    Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase of serum copper concentration in Löfgren syndrome.
    Donghi M; Giura R; Antonelli P
    Sarcoidosis; 1995 Sep; 12(2):147-9. PubMed ID: 8532964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioimmunological determination of thyrotropic hormone, triiodothyronine and thyroxine in lymphogranulomatosis during radiation and combined therapy].
    Simbirtseva LP; Iulbarisov AV; Lapchenkov VI; Borisova LIa
    Med Radiol (Mosk); 1983 Apr; 28(4):18-21. PubMed ID: 6835067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.